Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar, 608002, Tamilnadu, India.
Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar, 608002, Tamilnadu, India.
Biomed Pharmacother. 2018 Jul;103:539-545. doi: 10.1016/j.biopha.2018.04.066. Epub 2018 Apr 24.
Aberrations in the activities of key enzymes of carbohydrate metabolism is well documented in diabetes mellitus. Previous studies have shown that active ingredients in the extracts of Berberis aristata exhibits diverse pharmacological activities in animal models.
The present study was undertaken to investigate whether berbamine (BBM), an alkaloid from the roots of Berberis aristata can ameliorate the altered activities of carbohydrate metabolic enzymes in high fat diet (HFD)/streptozotocin (STZ) induced diabetic rats.
Supplementation of HFD for 4 weeks followed by intraperitonial administration of single low dose of STZ (40 mg/kg b.w.) to Sprague Dawley rats resulted in significant hyperglycemia with a decline in plasma insulin levels. The rats also exhibited decreased hemoglobin with an increase in glycated hemoglobin levels. The activities of hexokinase, glucose-6-phosphate dehydrogenase were decreased whereas increases in the activities of glucose-6-phosphatase and fructose-1,6-bisphosphatase were observed in the hepatic tissues of diabetic control rats. Glycogen content in the hepatic and skeletal muscle tissues were found to be decreased in diabetic rats. Oral administration of BBM for 56 days, dose dependently (50, 100, 200 mg/kg b.w.) improved insulin secretion in diabetic treated rats. Immunohistochemical studies on pancreas revealed a strong immunoreactivity to insulin in BBM treated rats. At the effective dose of 100 mg/kg b.w., BBM restored the altered activities of carbohydrate metabolic enzymes and also improved glycogen content in insulin dependent tissues.
From the biochemical and histochemical data obtained in this study we conclude that BBM ameliorated the activities of metabolic enzymes and maintained glucose homeostasis in HFD/STZ induced diabetic rats and it can be used as a potential phytomedicine for the management of diabetes mellitus.
糖尿病患者的糖代谢关键酶活性发生改变已有相关记载。先前的研究表明,小檗属植物提取物的活性成分在动物模型中表现出多种药理活性。
本研究旨在探讨小檗碱(BBM),一种从小檗属植物根部提取的生物碱,是否能改善高脂肪饮食(HFD)/链脲佐菌素(STZ)诱导的糖尿病大鼠糖代谢酶活性的改变。
连续 4 周给予 HFD,然后向 Sprague Dawley 大鼠腹腔内单次给予低剂量 STZ(40mg/kg体重),导致大鼠出现明显的高血糖,并伴有血浆胰岛素水平下降。大鼠的血红蛋白水平下降,糖化血红蛋白水平升高。与糖尿病对照组大鼠相比,肝组织中己糖激酶和葡萄糖-6-磷酸脱氢酶活性降低,而葡萄糖-6-磷酸酶和果糖-1,6-二磷酸酶活性升高。肝和骨骼肌组织中的糖原含量在糖尿病大鼠中减少。BBM 连续给药 56 天(50、100、200mg/kg体重),剂量依赖性地改善了糖尿病大鼠的胰岛素分泌。对胰腺进行免疫组织化学研究显示,BBM 处理大鼠的胰岛素反应强烈。在有效剂量 100mg/kg体重时,BBM 恢复了糖代谢酶的改变活性,并改善了胰岛素依赖组织中的糖原含量。
从本研究获得的生化和组织化学数据中,我们得出结论,BBM 改善了 HFD/STZ 诱导的糖尿病大鼠代谢酶的活性,维持了血糖稳态,可作为治疗糖尿病的潜在植物药。